Skip to main content
Premium Trial:

Request an Annual Quote

The $1.6 Billion SBIR Money Bus: Coming to a Town Near You

NEW YORK, July 24 - Hoping to help fund new life-science technology companies in the United States, representatives from the US National Institutes of Health and other federal agencies will be making stops at six northwestern towns to look for companies eligible for SBIR and STTR grants totaling $1.6 billion.


Officials will head to the following cities to hold one-on-one discussions with business owners, entrepreneurs, scientists, and researchers about how to apply for these grants:


·        Sept. 18--Boise, Idaho; Idaho Small Business Development Center

·        Sept. 19--Salt Lake City; Utah Centers of Excellence Program

·        Sept. 22--Reno, NV; NSBDC, Nevada Commission on Economic Development

·        Sept. 23--Sacramento, Calif.; Golden Capital Network, SARTA

·        Sept. 24--Portland, Ore.; Oregon Economic & Community Development Department

·        Sept. 25--Seattle; Washington Technology Center


"With technology advancing at a rapid rate and uncertain economic conditions, it is essential that we promote Federal funding opportunities to small businesses across the country--particularly in the Northwest, to help them stay competitive," Jo Anne Goodnight, SBIR/STTR program manager at NIH, said in a statement.

R&D program managers for one-on-one chats from the following agencies will be present: Department of Health and Human Services; National Science Foundation; Department of Education; Department of Defense's Defense Advanced Research Projects Agency, Special Operations Command, National Imagery and Mapping Agency, Departments of the Army, Navy, and Air Force; Department of Transportation; Department of Commerce; Environmental Protection Agency; NASA,  and Department of Energy.

The SBIR and STTR programs issue awards to US companies with 500 or fewer employees for R&D projects that have "commercialization potential in the private and/or public sector," according to the statement.

Click here for more information on SBIR and STTR awards.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.